Cite

HARVARD Citation

    Xu, R. et al. (2019). Combination strategies based on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for cancer patients. Medicine. 98 (13), p. . [Online]. 
  
Back to record